Portfolio company
Virion
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops T cell immunotherapies for patients with cancer and chronic infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vir Biotechnology
This company develops antibody-based medicines and immunotherapies for patients with serious infectious diseases and cancer.
T-Therapeutics
The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.
IconOVir
The company develops engineered oncolytic virus therapies to treat patients with solid tumours.
Vyriad
The company develops engineered virus platforms and genetic therapies for pharmaceutical partners and medical institutions to treat cancers and other genetic diseases.
Oncolytic virus therapies
This clinical-stage biotechnology company develops engineered oncolytic virus therapies for cancer patients to destroy tumours and stimulate the immune system.
Immunocore
This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.
T-Cypher Bio
The company develops T-cell receptor therapeutics and immune engagers for patients with cancer and autoimmune diseases.
VIRX
Viracta Therapeutics develops precision oncology medicines targeting virus-associated cancers for patients with Epstein-Barr virus-positive lymphomas and solid tumours.